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The pharmacological effect is achieved by regulating factors in ApoA1-
FABP-CPT1A pathway. DQP can also activate the expression of PPARa.
In addition, DQP shows anti-inﬂammatory effects by inhibiting PLA2-
COXs pathway mediated by NF-kB. This investigation lays foundation
for clinical application of DQP and provides insights into improving
the efﬁcacy in the treatment of CHD.
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OBJECTIVES Study the mechanism of Eliminating Sputum and
Removing Stasis Formulation improves Atherosclerotic Plaque via
regulating Mast Cell function on the ApoE-/- mice atherosclerotic
plaque model.
METHODS
1. Establishment and evaluation of artery atherosclerotic plaque model
on ApoE-/- mice.
2. We divided mouse into four groups randomly : control (CON), model
(MOD), atorvastain (ATO) and Traditional Chinese Medicine (TCM),
n¼10. After twelve weeks the difference of plaques proportion and the
leves of mast cell degranulation among all groups were compared
through HE, oil red O, and toluidine blue staining on the aortic root
slicing. We test the level of total cholesterol and total triglyceride by
related reagent kit (enzymic method). Mice plasma lipoprotein content
was tested by Fast Protein Liquid Chromatography. The Serum tryptase
activitywastestedbyColorimetricmethod.FinallyComparingallgroups’
mast cells genes expression via Quantitative PCR andWestern blot.
RESULTS We observe from the Aortic vascular root section staining
ﬁnding that the model can accelerate the artery plaques forma-
tion. Eliminating Sputum and Removing Stasis Formulation can im-
proves atherosclerotic plaques via reducing lipid load level in the
plaques (56%), weaken the degree of mast cell aggregation and
degranulation(35%).
Among all groups TCM is the most signiﬁcance on lower the level of
mice plasma TC (24%) and the activity of Tryptase (43%) compared
with MOD (P <0.05). The level of Low Density Lipoprotein (LDL) are
all descend on ATO and TCM (P >0.05).
The mast cell secretion related genes and proteins in aortic vascular
tissue such as LeukotrieneC4 synthase (34%), Histidine decarboxylase
(25%), Mast cell chymase1 (53%), Mast Cell Tryptase 6 (40%) decline
dramatically on TCM groups compared others (P <0.05). Meanwhile
the inﬂammatory factor in plasma such as the level of Tumor Necrosis
Factor a decreases 23% compared ATO (P <0.05) and the level of
transforming growth factor b1 rises 65% compared ATO (P <0.05).
CONCLUSIONS
1. Combine partial left carotid ligation with left kidney artery stenosis
operation and high-fat diet ApoE-/- mice can successfully be induced
atherosclerotic plaque formation.
2. The Traditional Chinese Medicine Eliminating Sputum and Removing
Stasis Formulation have the similar effect with atorvastatin on the
aspects of reducing lipid load in the plaques and lowering plasma LDL
levels.
3. Compared with atorvastatin, the mechanism of Eliminating Sputum
and Removing Stasis Formulation improves Atherosclerotic Plaque
may have extra effects on reducing the content of TC, weakening
mast cells aggregation and degranulation and adjusting the level of
TNF-a and TGF-b1 in the plasma.GW26-e3826
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OBJECTIVES Pharmacological preconditioning and postconditioning
may reduce myocardial necrosis and apoptosis during ischemia/
reperfusion (I/R). However, hypercholesterolemia interferes withtheir cardioprotective mechanisms. In the present study, we investi-
gated whether pharmacological preconditioning and postconditioning
with nicorandil could attenuate myocardial necrosis and apoptosis
induced by I/R in hypercholesterolemic rats and explored the possible
mechanisms involved.
METHODS 160 male Wistar rats were fed normal (normocholester-
olemic group, n¼10) or high-cholesterol (hypercholesterolemic group,
n¼150) diets for 8 weeks. Hearts isolated from normal and hyper-
cholesterolemic rats were placed on modiﬁed Langendorff perfusion
apparatus and subjected to 30-min global ischemia followed by 120-
min reperfusion. Nicorandil (1, 3, 10, 30, 100 mmol/l), mitochondrial
adenosine triphosphate sensitive potassium (mitoKATP) blocker
5-Hydroxydecanoic acid sodium salt (5-HD) (100 mmol/l), soluble
guanylyl cyclase (sGC) blocker 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-
1-one (ODQ) (10 mmol/l) were perfused for 10 min prior to ischemia or
at the onset of reperfusion. The myocardial infarct size was deter-
mined by triphenyltetrazolium chloride (TTC) staining, car-
diomyocyte apoptosis was detected by TUNEL staining. Expression of
caspase-3, Bax and Bcl-2 proteins were measured by Western blot
analysis to investigate the potential mechanisms.
RESULTS We found that pharmacological preconditioning and post-
conditioning with nicorandil reduced myocardial necrosis and
apoptosis induced by I/R in a concentration-dependent manner in
hypercholesterolemic rats. The optimal concentration of nicorandil
preconditioning and postconditioning in anti-infarct and anti-
apoptosis was 30mmol/l. 30mmol/l nicorandil preconditioning and
postconditioning reduced the infarct size to 14.883.25% and
15.963.29%, attenuated the percentage of cardiomyocyte apoptosis
to 25.203.93% and 26.184.82%, respectively. While, the car-
dioprotection of nicorandil were partly suppressed by cotreatment
with 5-HD or ODQ. Western blot analysis showed that pharmacological
preconditioning and postconditioning with nicorandil downregulated
caspase-3 and Bax expression, and upregulated Bcl-2 expression
compared with the I/R group (P<0.05).
CONCLUSIONS Taken together, these data suggested that pharma-
cological preconditioning and postconditioning with nicorandil pro-
tected hypercholesterolemic hearts against necrosis and apoptosis
induced by I/R, and this cardioprotective effects of nicorandil was due
to its dual pharmacological mechanisms of opening the mitoKATP
channels and nitric oxide (NO)/sGC dependent mechanism, and the
regulation of the expression of caspase-3, Bax and Bcl-2.GW26-e4697
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OBJECTIVES This work aims to test the hypothesis that effect of Cx37
gene decreased myocardial fractional ﬂow reserve.
METHODS Lentiviruses carrying small interfering RNA (siRNA) of
Cx37 gene were constructed, which signiﬁcantly knocked down mRNA
and protein expression of Cx37 gene in vitro. Sixty pigs with high-fat
diet were randomly divided into saline, mock, and different concen-
trations Cx37 viral suspension to induce coronary plaque formation.
Different levels Cx37 viral suspension, saline and mock after per-
forming myocardial fractional ﬂow reserve (FFR) were transfected
into the related coronary. After two weeks, four weeks, six weeks and
eight weeks, myocardial fractional ﬂow reserve were measured by
intravascular ultrasound (IVUS) and After eight weeks plaque char-
acteristics were detected. The expression of Cx37 mRNA was detected
by semi-quantitative RT-PCR. The expression of CX37 protein was
demonstrated by Western blot.
RESULTS Four weeks, six weeks and eight weeks after lentivirus
transfection, FFR in siRNA Cx37 (20 ml) was higher than in siRNA Cx37
(10 ml), in siRNA Cx37 (5 ml) in the mock-siRNA group and in the saline
group. Cx37 mRNA levels were lower by 41% in the Cx37 siRNA group
(20 ml), by 81% in the Cx37 siRNA group (10 ml), by 84% in the Cx37
siRNA group (5 ml), by 95% in the mock-siRNA group, and by 97% in
the saline group (P < 0.05). The mock group showed no signiﬁcant
change in Cx37compared with the saline group. Cx37 protein was
lower in the siRNA Cx37 group (20 ml) than in other groups (0.210.05
vs. 0.780.06 vs. 0.720.08 ,0.870.05 and 0.840.06).
CONCLUSIONS SiRNA can be used to efﬁciently knock down
Cx37genes in coronary plaques of pigs. At the same time, FFR in the
siRNA Cx37 group (20 ul) was improved.
